Since STAT3 is a potential drug target for colon cancer therapy (32), therefore, the purpose of our study was to explore the combination effect of AF and ICG-001 on colon cancer and the underling mechanism related to STAT3. The gene discussed is STAT3; the disease is malignant colon neoplasm.